In addition, 20–30% of breast cancers are triple-negative breast cancers (TNBC), lacking ER, PR and Her2 with more aggressive clinical course than other forms of breast cancer, increased local/systemic relapse and poor survival [2–4]. This evidence concerns the gene PGR and breast carcinoma.